Akonni Biosystems Gets $3M Grant for Drug-Resistant Genotyping Test

Akonni is developing a multi-drug resistant/extensively drug-resistant (MDR/XDR) genotyping testing technology for the point-of-care setting.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.